Online 2020 Gangnam Medi Tour Festa to be Held Until Dec. 31
{window.open('http://service.weibo.com/share/share.php?url='+encodeURIComponent(location.href)+'&type=button&ralateUid=1649036617&language=zh_cn&appkey=1943563082&title='+encodeURIComponent('Online 2020 Gangnam Medi Tour Festa to be Held Until Dec. 31 ')+'&pic=http://mma.prnasia.com/media2/1336048/main_screen_online_festival.jpg?p=medium600&searchPic=true&style=simple','_blank','width=650,height=450');})()){kind=link}
SEOUL, South Korea, Nov. 24, 2020 /PRNewswire/ -- Gangnam-gu, a district globally famous as Mecca for medical tourism, opened its 2020 Online Gangnam Medi Tour Festa for foreign patients who find visits to Korea difficult during the COVID-19 pandemic.
Main screen of the online festival
The entire event will be held online through the festival's official website (https://gangnammeditour.kr/), and visitors can get a full glance into the 105 excellent medical institutions as well as receive free consultations via video calls, chats and emails.
Anyone who consults with experts and makes reservations during the festival period will receive a discount as part of the early-bird event. The event is highly recommended as the expiration date is extended for participants to use the discount even after the end of the COVID-19 pandemic.
The online 2020 Gangnam Medi Tour Festa is scheduled to take place until Dec. 31.
Featured Video
Health Care/Hospital Recent Releases
- Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease
- USANA Provides Sustainable Nutrition to Malapascua Island Through Garden Tower Project
- Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
- Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA
- Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite
- Read more
Medical/Pharmaceuticals Recent Releases
- Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease
- Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
- Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA
- Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite
- Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody Discovery
- Read more
Travel Recent Releases
- Ocean Park Hong Kong: A World Where Every Smile Counts
- Trip.com Group Limited Reports Unaudited First Quarter of 2024 Financial Results
- Press Statement from Hard Rock International Related to Star Entertainment Announcement
- Sanya Marks Sixth Anniversary of Establishing the Hainan FTP with Pledge to Boost Global Tourism Influence
- Air Premia Launches New Service on San Francisco-Incheon Route, Operating Four Times Weekly
- Read more